TSC1 regulates the balance between effector and regulatory T cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Mammalian target of rapamycin (mTOR) is critical for T cell differentiation.
• The precise regulatory mechanisms of the mTOR pathway in T cells remain incompletely understood.
• Tuberous sclerosis 1 (TSC1) is an upstream negative regulator of mTOR.

Purpose of the Study:

• To investigate the role of TSC1 in T cell fate determination and immune homeostasis.
• To elucidate the regulatory mechanism of mTOR pathway in T cell differentiation and function.

Main Methods:

• Generated T cell-specific Tsc1 knockout mice.
• Utilized conditional knockout models for Tsc1 deletion in regulatory T cells (Tregs).
• Performed fate-mapping studies and in vivo knockdown experiments.

Main Results:

• T cell-specific deletion of Tsc1 augmented Th1 and Th17 differentiation, causing severe intestinal inflammation.
• Conditional Tsc1 deletion in Tregs impaired their suppressive activity, Foxp3 expression, and increased IL-17 production.
• Tsc1-null Tregs exhibited an effector-like phenotype, and elevated IL-17 was linked to mTOR signaling via S6K1.

Conclusions:

• TSC1 is essential for maintaining immune homeostasis by controlling T cell fate.
• Dysregulation of TSC1 impacts Treg function and promotes inflammatory responses.
• TSC1 acts as a critical checkpoint in regulating immune cell differentiation and function.